"FDA procedure called accelerated approval in which the FDA approves drugs that show great promise in phase II, with the caveat that the drug sponsor must still perform confirmatory phase III studies. If the phase III studies ultimately show that the drug doesn’t work as advertised, or has previously unknown safety issues, the FDA can revoke its approval. "
Feel that would be quite a long shot. New compound, semi-related to anabolics. Unless a drug is curing cancer, FDA seems very unlikely to bypass phase 3's. If phase 2's go well, it could save them time and energy in phase 3 though, in a number of ways. Great question though. Glad to have you still with us, hope summer is treating you well
News 
Market Data 
Discover 
AI
